We are live on ! Find out more
EGM

Encore Global Management Portfolio holdings

AUM $102M
This Fund
S&P 500
This Quarter Est. Return
+21.92%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
-$41.4M
Cap. Flow
-$52.7M
Cap. Flow %
-51.72%
Top 10 Hldgs %
40.03%
Holding
74
New
4
Increased
15
Reduced
19
Closed
21

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.69M
2
ZTS icon
Zoetis
ZTS
+$2.26M
3
CRSP icon
CRISPR Therapeutics
CRSP
+$1.61M
4
BSX icon
Boston Scientific
BSX
+$1.48M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.44M

Top Sells

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$4.89M
2
MRVL icon
Marvell Technology
MRVL
+$4.75M
3
BP icon
BP
BP
+$4.41M
4
JNJ icon
Johnson & Johnson
JNJ
+$4.4M
5
NTRS icon
Northern Trust
NTRS
+$3.36M

Sector Composition

Rank Sector Weight
1 Technology 42.38%
2 Healthcare 17.18%
3 Energy 10.16%
4 Communication Services 10.03%
5 Financials 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
26
CRISPR Therapeutics
CRSP
$5.58B
$1.67M 1.64%
+30,557
New +$1.61M
NTRA icon
27
Natera
NTRA
$47B
$1.63M 1.6%
6,000
– –
AVGO icon
28
Broadcom
AVGO
$1.75T
$1.51M 1.48%
4,000
-500
-11% -$200K
TMUS icon
29
T-Mobile US
TMUS
$195B
$1.51M 1.48%
9,000
+3,000
+50% +$568K
EQT icon
30
EQT Corp
EQT
$34.1B
$1.49M 1.46%
28,000
– –
FANG icon
31
Diamondback Energy
FANG
$55.4B
$1.23M 1.21%
7,000
– –
AR icon
32
Antero Resources
AR
$11.8B
$1.23M 1.21%
35,000
+6,000
+21% +$221K
GEV icon
33
GE Vernova
GEV
$243B
$1.17M 1.15%
+1,000
New +$1.02M
CYTK icon
34
Cytokinetics
CYTK
$10B
$1.08M 1.06%
12,731
+7,731
+155% +$555K
KO icon
35
Coca-Cola
KO
$386B
$1.07M 1.05%
13,200
-19,800
-60% -$1.56M
C icon
36
Citigroup
C
$223B
$980K 0.96%
7,000
-6,750
-49% -$879K
RGTI icon
37
Rigetti Computing
RGTI
$5.2B
$939K 0.92%
48,600
-71,400
-60% -$1.38M
T icon
38
AT&T
T
$178B
$828K 0.81%
40,000
-59,750
-60% -$1.48M
BABA icon
39
Alibaba
BABA
$296B
$768K 0.75%
8,000
+4,000
+100% +$501K
OVV icon
40
Ovintiv
OVV
$17.9B
$737K 0.72%
14,000
– –
QBTS icon
41
D-Wave Quantum Inc
QBTS
$6.33B
$720K 0.71%
30,000
– –
IONQ icon
42
IonQ
IONQ
$15.9B
$666K 0.65%
12,500
-7,500
-38% -$380K
MDLZ icon
43
Mondelez International
MDLZ
$79.6B
$578K 0.57%
10,000
-45,000
-82% -$2.71M
TRGP icon
44
Targa Resources
TRGP
$61.7B
$536K 0.53%
2,000
– –
ADBE icon
45
Adobe
ADBE
$116B
$513K 0.5%
2,500
-10,800
-81% -$2.56M
DVN icon
46
Devon Energy
DVN
$52.1B
$413K 0.41%
10,000
– –
HON icon
47
Honeywell
HON
$68.9B
$269K 0.26%
1,200
-1,200
-50% -$268K
HONA
48
Honeywell Aerospace
HONA
$51.5B
$265K 0.26%
+1,200
New +$265K
WMT icon
49
Walmart Inc
WMT
$820B
$113K 0.11%
1,000
– –
RPRX icon
50
Royalty Pharma
RPRX
$27.1B
$112K 0.11%
+2,000
New +$104K
1
2
3

Similar funds

LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return
PCP
Pantera Capital Partners San Francisco, California $102M AUM 45.76% 1-Year Est. Return
MC
MSD Capital New York $102M AUM 2.45% 1-Year Est. Return
PWM
Partners Wealth Management Carmel By The Sea, California $102M AUM 23.71% 1-Year Est. Return
ECP
Electric Capital Partners Palo Alto, California $102M AUM
EFA
Englebert Financial Advisers Allentown, Pennsylvania $102M AUM
ACMA
Arbor Capital Management (Alaska) Anchorage, Alaska $102M AUM 14.51% 1-Year Est. Return
GHA
Good Harbor Advisors Gloucester, Massachusetts $102M AUM

Encore Global Management's Q2 2026 Portfolio in Review

As of Q2 2026, Encore Global Management held 74 positions worth $102M, down 29% from $143M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Encore Global Management withdrew a net $52.7M in Q2 2026, closing 21 positions and reducing 19 holdings. Its most notable exit was Valero Energy, an estimated $4.89M position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 30% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Encore Global Management opened a new position in CRISPR Therapeutics worth $1.67M.

  • Encore Global Management's largest Q2 2026 buy was CRISPR Therapeutics: 30,557 shares worth $1.67M.
  • Encore Global Management added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $2.69M increase.
  • Encore Global Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $4.75M.
  • Encore Global Management fully exited Valero Energy in Q2 2026, selling an estimated $4.89M.
  • Encore Global Management's ten largest holdings make up 40% of its $102M portfolio in Q2 2026.
  • Encore Global Management opened 4 new positions and closed 21 in Q2 2026.
  • Encore Global Management's portfolio value fell 29% quarter-over-quarter to $102M.

Based on Encore Global Management's 13F filing for Q2 2026, filed 11 Aug 2026.